LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

Начало・Списък с акции・Anavex Life Sciences Corp

Anavex Life Sciences Corp

Затворен

СекторЗдравеопазване

2.7 0.37

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.64

Максимум

2.79

Ключови измерители
By Trading Economics
Приходи	4.1M -5.7M
Служители	34
EBITDA	3.1M -6.8M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+640.74% upside

Дивиденти
By Dow Jones
Следващи печалби	2.06.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-139M 250M
Предишно отваряне	2.33
Предишно затваряне	2.7

Настроения в новините

By Acuity

50%

154 / 344 Класиране в Healthcare

Anavex Life Sciences Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.05.2026 г., 16:52 ч. UTC

Значими събития в новините

NYMEX Overview: Brent Crude Futures Up; Iran Warns of Retaliation After US Strike -- OPIS

26.05.2026 г., 23:57 ч. UTC

Печалби

Sociedad Quimica 1Q Rev $1.76B >SQM

26.05.2026 г., 23:57 ч. UTC

Печалби

Sociedad Quimica 1Q EPS $1.28 >SQM

26.05.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise on Continued AI Enthusiasm -- Market Talk

26.05.2026 г., 21:54 ч. UTC

Печалби

Webco Industries 3Q EPS $11.61 >WEBC

26.05.2026 г., 21:54 ч. UTC

Печалби

Webco Industries 3Q Sales $179.6M >WEBC

26.05.2026 г., 21:48 ч. UTC

Пазарно говорене

GE Aerospace's Repair Boom Should Last for Years -- Market Talk

26.05.2026 г., 21:00 ч. UTC

Пазарно говорене

ESG Roundup: Market Talk

26.05.2026 г., 20:58 ч. UTC

Придобивния, сливания и поглъщания

Uber's $11.6 Billion Bid for DoorDash Rival Is About Future Proofing It From Robots -- Barrons.com

26.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

26.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

26.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

26.05.2026 г., 19:22 ч. UTC

Пазарно говорене

Cryptocurrencies Add to Losses in Afternoon Trading -- Market Talk

26.05.2026 г., 19:17 ч. UTC

Пазарно говорене

Oil Recovers Some Losses on U.S.-Iran Skirmishes -- Market Talk

26.05.2026 г., 18:56 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Slip in Rangebound Trading -- Market Talk

26.05.2026 г., 18:03 ч. UTC

Пазарно говорене

AutoCanada Faces Soft Demand, Slow Normalization -- Market Talk

26.05.2026 г., 17:42 ч. UTC

Пазарно говорене

Grains Await Fresh Trading Catalyst -- Market Talk

26.05.2026 г., 17:33 ч. UTC

Пазарно говорене

Salesforce, Snowflake Could Dispel Software Bear Thesis -- Market Talk

26.05.2026 г., 17:21 ч. UTC

Пазарно говорене

Canada Faces a Labor Market Squeeze -- Market Talk

26.05.2026 г., 16:52 ч. UTC

Пазарно говорене

Bonds to Fund Infrastructure for Data Centers Could Be Risky -- Market Talk

26.05.2026 г., 16:43 ч. UTC

Пазарно говорене

Spotify's Latest Audio Play: Magazine Articles -- Market Talk

26.05.2026 г., 16:24 ч. UTC

Пазарно говорене

Dollarama's LATAM Slowdown, Australia Costs Seen as Transient -- Market Talk

26.05.2026 г., 16:21 ч. UTC

Пазарно говорене

Oil Extends Gains As Strikes Add Tension to U.S.-Iran Talks -- Market Talk

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Auto & Transport Roundup: Market Talk

26.05.2026 г., 16:16 ч. UTC

Пазарно говорене

Alberta Separation Threat Poses Headwind for Canada Dollar -- Market Talk

26.05.2026 г., 16:01 ч. UTC

Пазарно говорене

Bitcoin Lower as Stress Builds for Holders -- Market Talk

26.05.2026 г., 15:21 ч. UTC

Пазарно говорене

Hyperliquid Pushes Up to New All-Time High -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Anavex Life Sciences Corp Прогноза

Ценова цел

By TipRanks

640.74% нагоре

12-месечна прогноза

Среден 20 USD 640.74%

Висок 20 USD

Нисък 20 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Anavex Life Sciences Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Anavex Life Sciences Corp през последните 3 месеца.

Настроение

By Acuity

154 / 344 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Anavex Life Sciences Corp

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.